Lv1
60 积分 2024-03-15 加入
Efficacy and Safety of Sunvozertinib Monotherapy as First-line Treatment in NSCLC Patients with EGFR Exon 20 Insertion Mutations: A Phase 2, Single-center Trial
20小时前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
20小时前
已完结
Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib
1个月前
已完结
Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein–overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib
2个月前
已完结
Activating mutations in the MET kinase domain co-occur with other driver oncogenes and mediate resistance to targeted therapy in NSCLC
2个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
2个月前
已完结
MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study
2个月前
已完结
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
2个月前
已完结
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
3个月前
已完结
Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients
4个月前
已采纳
Two public chest X-ray datasets for computer-aided screening of pulmonary diseases
4个月前
已采纳
Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia
4个月前
已驳回
皖公网安备34019202002308
